Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Gynecologic Oncology|November 19, 2022
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trialBenoit You, Pierre-Adrien Bolze, Jean-Pierre Lotz, et al.Clinical Chemistry|January 5, 2021
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization TestAntonin Bal, Bruno Pozzetto, Mary-Anne Trabaud, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2020
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II TrialBenoit You, Pierre-Adrien Bolze, Jean-Pierre Lotz, et al.Bulletin of Entomological Research|May 16, 2020
Targeted outdoor residual spraying, autodissemination devices and their combination against <i>Aedes</i> mosquitoes: field implementation in a Malaysian urban settingNurulhusna Ab Hamid, Neal Alexander, Remco Suer, et al.The Lancet. Infectious Diseases|May 15, 2025
Effectiveness of integrated vector management on the incidence of dengue in urban Malaysia: a cluster-randomised controlled trialMitra Saadatian-Elahi, Muriel Rabilloud, Tim W R Möhlmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axisYasmine Touil, Wassila Igoudjil, Matthieu Corvaisier, et al.JAMA Oncology|June 11, 2026
Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors: The TROPHAMET Phase 1/2 Nonrandomized Clinical TrialBenoit You, Jean-Pierre Lotz, Pierre Descargues, et al.European Journal of Neurology|October 29, 2024
Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta-analysis of an N-of-1 trialChloé Laurencin, Aurelia Poujois, Maxime Bonjour, et al.Ebiomedicine|December 27, 2019
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patientsBenoit You, Frédéric Mercier, Eric Assenat, et al.Histopathology|February 28, 2023
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortiumYasodha Natkunam, Daphne de Jong, Pedro Farinha, et al.Pageof 6